Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romijn

Showing results (951-960 of 994) with videos related to

Pageof 100
Sort By:
Journal of Internal Medicine|March 27, 2010
Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative studyB G Brouwer, F L J Visseren, A Algra, et al.
Circulation|December 1, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary SyndromeSotirios Tsimikas, Michael Szarek, Christa M Cobbaert, et al.
Circulation|April 8, 2009
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitusRutger W van der Meer, Luuk J Rijzewijk, Hugo W A M de Jong, et al.
Veterinary Journal (London, England : 1997)|March 4, 2008
In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factorBrigitte Arends, Bart Spee, Gaby Hoffmann, et al.
Journal of the American College of Cardiology|July 13, 2010
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetesLuuk J Rijzewijk, Jacqueline T Jonker, Rutger W van der Meer, et al.
American Journal of Preventive Cardiology|June 15, 2026
Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatmentGregory G Schwartz, Michael Szarek, Christa M Cobbaert, et al.
British Journal of Anaesthesia|June 6, 2025
Characteristics and outcome of preoperative multidisciplinary team discussions for high-risk noncardiac surgical patients in the Netherlands: a multicentre prospective observational studyJacqueline E M Vernooij, Elisha Hobrink, Romijn M Boerlage, et al.
British Journal of Pharmacology|February 5, 2014
Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltrationY Wang, E T Parlevliet, J J Geerling, et al.
Archives of Biochemistry and Biophysics|September 23, 2015
A single night of sleep curtailment increases plasma acylcarnitines: Novel insights in the relationship between sleep and insulin resistanceRosa van den Berg, Dennis O Mook-Kanamori, Esther Donga, et al.
The Journal of Applied Laboratory Medicine|September 6, 2024
Quality Assurance for Multiplex Quantitative Clinical Chemistry Proteomics in Large Clinical TrialsEsther Reijnders, Fred P H T M Romijn, Figen Arslan, et al.
Pageof 100

Showing results (951-960 of 994) with videos related to

Sort By:
Pageof 100
Journal of Internal Medicine|March 27, 2010
Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative studyB G Brouwer, F L J Visseren, A Algra, et al.
Circulation|December 1, 2025
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary SyndromeSotirios Tsimikas, Michael Szarek, Christa M Cobbaert, et al.
Circulation|April 8, 2009
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitusRutger W van der Meer, Luuk J Rijzewijk, Hugo W A M de Jong, et al.
Veterinary Journal (London, England : 1997)|March 4, 2008
In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factorBrigitte Arends, Bart Spee, Gaby Hoffmann, et al.
Journal of the American College of Cardiology|July 13, 2010
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetesLuuk J Rijzewijk, Jacqueline T Jonker, Rutger W van der Meer, et al.
American Journal of Preventive Cardiology|June 15, 2026
Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatmentGregory G Schwartz, Michael Szarek, Christa M Cobbaert, et al.
British Journal of Anaesthesia|June 6, 2025
Characteristics and outcome of preoperative multidisciplinary team discussions for high-risk noncardiac surgical patients in the Netherlands: a multicentre prospective observational studyJacqueline E M Vernooij, Elisha Hobrink, Romijn M Boerlage, et al.
British Journal of Pharmacology|February 5, 2014
Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltrationY Wang, E T Parlevliet, J J Geerling, et al.
Archives of Biochemistry and Biophysics|September 23, 2015
A single night of sleep curtailment increases plasma acylcarnitines: Novel insights in the relationship between sleep and insulin resistanceRosa van den Berg, Dennis O Mook-Kanamori, Esther Donga, et al.
The Journal of Applied Laboratory Medicine|September 6, 2024
Quality Assurance for Multiplex Quantitative Clinical Chemistry Proteomics in Large Clinical TrialsEsther Reijnders, Fred P H T M Romijn, Figen Arslan, et al.
Pageof 100